{
    "nctId": "NCT02865304",
    "briefTitle": "The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients",
    "officialTitle": "The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative Metastatic Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Angiogenesis, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "overall response rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women with ages between 18-70 years with histologically confirmed MBC documented as HER-2-negative\n\nExclusion Criteria:\n\n* cannot tolerated chemotherapy\n* cardiac insufficiency",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}